BioSig Technologies appoints Chris Baer to board of directors

Streamex Corp.

Chris Baer appointed as director effective May 2, 2024; term expires at next annual meeting.
Baer brings over 25 years commercial experience in medical devices; current CCO at CDL Nuclear Technologies.
He will serve on audit, nominating, and compensation committees.
Previously held VP/GM roles at St. Jude Medical/Abbott and VP of Commercial Operations at Impulse Dynamics.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Chris Baer

director

STEX · Streamex Corp.

Effective: 2024-05-02
Filed: May 2, 2024, 7:59 PM ET

On May 2, 2024, the board of directors of BioSig Technologies, Inc. (the “Board”) appointed Mr. Chris Baer as a director on the Board.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Chris Baer was appointed as director at Streamex Corp..

Action: appointed
Role: director

Exact text from the filing

On May 2, 2024, the board of directors of BioSig Technologies, Inc. (the “Board”) appointed Mr. Chris Baer as a director on the Board.

View on SEC.gov

Streamex Corp. filing history →

Source: SEC EDGAR

accession 0001493152-24-017546

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.